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ABSTRACT  We  have  determined  the  biochemical  and  immunocytochemical  localization  of 
the heterogeneous microtubule-associated protein tau using a monoclonal antibody that binds 
to all  of the  tau  polypeptides  in  both  bovine  and  rat  brain.  Using  immunoblot  assays and 
competitive  enzyme-linked  immunosorbent assays, we have shown tau to be more abundant 
in  bovine white matter extracts and microtubules than  in extracts and  microtubules from  an 
enriched gray matter region of the brain. On a per mole basis, twice-cycled microtubules from 
white matter contained three times  more tau than did twice-cycled  microtubules from  gray 
matter. Immunohistochemical  studies that compared the localization of tau with that of MAP2 
and  tubulin  demonstrated  that  tau  was  restricted  to  axons,  extending  the  results  of  the 
biochemical  studies. Tau localization  was not observed  in glia,  which  indicated that, at least 
in  brain,  tau  is  neuron  specific.  These  observations  indicate  that  tau  may  help  define  a 
subpopulation  of  microtubules  that  is  restricted  to  axons.  Furthermore,  the  monoclonal 
antibody  described  in  this  report  should  prove  very  useful to  investigators  studying axonal 
sprouting and growth because it is an exclusive axonal marker. 
Of the  numerous  microtubule-associated proteins (MAPs) ~ 
(40) that co-purify with brain tubulin through repetitive cycles 
of temperature-dependent assembly and disassembly, MAP2 
and tau have been most extensively studied. In particular, the 
high  molecular weight protein MAP2  (Mr >  300,000)  has 
received considerable attention. Immunocytochemical studies 
have shown that MAP2 does not localize in most glia but is 
highly concentrated in neuronal cell bodies and dendrites (2, 
9, 13, 2 l, 32). Most axons do not exhibit anti-MAP2 staining, 
in  agreement with  axoplasmic transport  studies  on retinal 
ganglion cells, which have failed to detect transport of MAP2 
(5, 46). However, some axons contain detectable amounts of 
MAP2. Light MAP2 immunoreactivity is apparent in certain 
axonal subpopulations in the brain proper (9,  17), whereas 
some axons of the peripheral nervous system stain intensely 
with monoclonal antibodies to MAP2 (34).  These observa- 
tions are supported by biochemical studies on microtubules 
purified from white matter, which demonstrate the presence 
of small amounts of MAP2 (48). However, with these notable 
exceptions,  the  majority  of axons  display  little  detectable 
Abbreviations used in this paper." ELISA, enzyme-linked immuno- 
sorbent assay; MAP, microtubule-associated  protein; TBS, 50 mM 
Tris-HC1, 130 mM NaC1, 5 rnM KC1, 5 mM MgSO4, l mM EGTA, 
0.05% NAN3, pH 7.6. 
MAP2, indicating that MAP2 is primarily a dendritic protein 
(2, 9,  13, 17, 21, 34). 
MAP2 is a high molecular weight, heat stable  doublet of 
polypeptides (24),  and tau  is  also  heat  stable but of lower 
molecular weight (Mr 52,000-68,000) (11). Tau is more elec- 
trophoreticaUy heterogeneous. Depending upon the species 
under study, tau  associated with twice-cycled microtubules 
has been observed as a single electrophoretic species (guinea 
pig), three sharply resolved polypeptides (mouse), four poorly 
resolved polypeptides (rat) (16), or four sharply resolved poly- 
peptides (bovine) (11, 15). Early studies (10, 1  l) demonstrated 
that, although electrophoretically  heterogeneous, the tau poly- 
peptides have nearly identical peptide maps, leading to much 
speculation as to the nature and purpose of tau's diversity. 
Both MAP2 and tau stoichiometrically stimulate microtubule 
assembly in vitro (l l, 24, 28, 33, 41, 51) and bind along the 
entire length of the polymer (reference 24 and Binder, L. I., 
and L. I. Rebhun, manuscript in preparation). 
During brain maturation, MAP2 and tau have been shown 
to  undergo  changes in  electrophoretic mobility, indicating 
either the activation of new genes or the occurrence of  a series 
of posttranslational modifications (4, 7,  15,  16,  18, 30). Al- 
though the functional implications of  these alterations are not 
known, the immature forms of  MAP2 and tau are less efficient 
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corresponding adult forms (16). The latter result suggests that 
microtubules in  immature brain  are less  stable  than  those 
found in the adult. It is interesting to note that these devel- 
opmental changes in MAPs accompany a marked increase in 
the  number of both  alpha-  and  beta-tubulin  isotypes (14), 
suggesting the existence of many classes of microtubules, each 
of which  may perform  a  series  of specialized tasks within 
neurons and glia. 
Although much is known about the intracellular localiza- 
tion of certain MAPs and tubulin (2,  6,  9,  13,  21,  31,  35), 
nothing has been  reported regarding the localization of the 
tau polypeptides  in  brain.  Early studies using a  polyclonal 
antibody to tau demonstrated that staining could be obtained 
in  certain  fibroblasts  but  not  in  a  glioma  cell  line  (12). 
Available evidence suggests that, in vitro, MAP2 and tau can 
compete for the same class of binding sites on the microtubule 
wall (23,  38).  Therefore, the possibility exists that they may 
not coexist in the same intracellular compartment in situ. To 
investigate the possibility that tau and MAP2 are differentially 
compartmentalized  we  have  isolated  and  characterized  a 
monoclonal antibody that binds to all of the tau polypeptides 
in both bovine and rat brains. Using this antibody we have 
demonstrated biochemically (in bovine brain) and immuno- 
cytochemically (in rat brain) that tau is primarily localized in 
axons. 
MATERIALS  AND  METHODS 
Monoclonal Antibody  Selection and Production:  BALB/c 
mice were immunized with phosphocellulose-purified (51) bovine MAPs, which 
were denatured  by boiling in 0.1% SDS. Immunization was performed over a 
period  of 2  me, with  the initial  injection  performed  in  Freund's complete 
adjuvant  and  subsequent injections  (at  2-wk  intervals)  carried  out  using 
Freund's incomplete adjuvant.  Each injection contained  at least 0.5 mg SDS- 
denatured  bovine MAPs administered at both an interperitoneal  and a subcu- 
taneous site.  5  d  before  fusion,  a  final  injection  was administered  to two 
animals. Immunized spleens were dissected and dissociated, and the splenocytes 
were fused with SP2/o myeloma cells by the procedure of Kohler and Milstein 
(25, 26) as modified (49). The resultant hybrid cells were plated in  12 96-well 
culture  dishes on a thymocyte  feeder layer in RPMI medium supplemented 
with 15% horse serum, and 24 h after plating this medium was exchanged with 
selection  medium containing  hypoxanthine,  aminopterin,  thymidine.  Clone 
formation  was observed within 7 d and most wells were confluent  14 d after 
fusion. Of the  1,156 wells plated,  1,155 were positive for hybrid  formation. 
Antibody  production  was assayed  by enzyme-linked  immunosorbant assay 
(ELISA) (50) (see below, Quantitative  ELISA) using phosphocellulose MAPs 
in the solid phase. Of  the 1,155 wells assayed, >800 were positive for anti-MAP 
antibody production.  156 of  the most intensely positive clones were picked and 
expanded into  l-ml cultures. Upon reaching confluence, the individual clones 
were frozen in complete  medium that contained  25%  horse serum and  10% 
dimethyl sulfoxide. Aliquots of spent medium from each clone were tested by 
ELISA for binding to purified bovine MAP2 or tau. Of the  156 clones frozen, 
31  expressed  antibody  to  MAP2  whereas  only  6  produced  antibody  that 
recognized bovine tau. The antibody-containing  media from these six putative 
tau clones were tested on immunoblots of  whole rat brain. Only one line, Tau- 
l, was cross-reactive in rat brain, exhibiting binding to several polypeptides in 
the  tau  region of the gel. This line was thawed  and subcloned  twice before 
injection  into a  BALB/c  mouse for the production  of antibody-containing 
ascites fluid. Cells obtained  from sterilely drained  ascites fluid were harvested 
by centrifugation,  cultured,  and subcloned  once more before freezing. I 1 ml 
ascites fluid was harvested from one mouse and chromatographed  on protein 
A-Sepharose,  yielding nearly 30 mg of Tau-l antibody at a final concentration 
of 0.96 mg/ml. Except for fluctuation  analysis, this affinity-purified antibody 
was used in all of the biochemical experiments described below. Immunocyto- 
chemistry  was performed  using spent tissue culture  medium harvested from 
stationary phase Tau-l-producing hybridomas. 
The MAP2 and tubulin monoclonal antibodies used in this study were those 
described by Caceres et al. (9). 
Protein Determination,  SDS  PAGE, and  Immunoblotting 
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Procedures:  Protein  determinations  were performed  by  the  method of 
Lowry et al. (29) as modified (I). SDS potyacrylamide slab gels (17 x  t 1.5 x 
0.15 cm) were of  the formulation of Laemmli (27). The separating gel consisted 
of a 32-ml, 5-12%  linear acrylamide gradient. Electrophoresis was performed 
at 20-mA constant current until the tracking dye reached the bottom of the gel 
(~7 h). After electrophoresis, gels were either stained with Coomassie Brilliant 
Blue R  or transferred  to nitrocellulose for subsequent  immunoblot analysis. 
Transfer  of polypeptides to nitrocellulose was performed  by the  method  of 
Towbin et al. (45) with the exception that 130 mA constant current for 6 h was 
used to effect transfer.  Blotted nitrocellulose  sheets were blocked by gentle 
agitation in 5% nonfat dry milk (weight/volume) in 50 mM Tris-HC1, pH 7.6, 
0.2 M NaCl (Tris-saline) for 45 rain at room temperature (22) before overnight 
incubation  at 4"C in 20 pg/ml of Tau-l antibody in Tris-saline. After primary 
antibody incubation, blots were washed in Tris-saline and blocked again for 15 
rain in 5% nonfat dry milk, Tris-saline, and then placed in the same solution 
containing  a  1/5,000 dilution  of peroxidase conjugated goat anti-mouse IgG 
(Hyclone, Prove, UT) for 2-3 h at 4"C. The blots were then washed again three 
or  four times  in  Tris-saline  and  placed into  substrate  solution  containing 
0.0075% (vol/vol) H202, 0.04% (wt/vol) 3, 3' diaminobenzidine  tetrahydroch- 
loride in 50 mM Tris,  l0 mM imidazole-HCl, pH 7.6 (43). The reaction was 
stopped after sufficient color had developed (~2-3 rain) by immersing the blot 
in deionized water. After air drying on filter paper, the blots were photographed 
using a dark blue filter. 
Microtubule Protein Purification:  Microtubules were purified by 
the assembly-disassembly procedure ofShelanski et al. (39). Bovine brain tissue 
was dissected from either  the head of the  caudate  nucleus  (gray matter)  or 
internal  capsule (white matter)  and suspended at a ratio  of 1 g tissue/rot  of 
polymerization buffer containing  100 mM Pipes, pH 6.8, l mM MgSO,, 2 mM 
EGTA, 0. l mM GTP. After homogenization  and centrifugation in the cold at 
I l 0,000 g for l h, the supernatant  was removed and either stored as "crude" 
or "soluble" extracts or used for microtubule  purification.  Assembly, centrif- 
ugation, and cycling of microtubule  protein  were as described by Kim et al. 
(24). Tubulin was purified from twice-cycled microtubules  using phosphocel- 
lulose chromatography (5 l). MAP2 and tau were purified by a modification of 
the method of Kim et al. (24) using heat precipitation and chromatography of 
the  heat-stable fraction  in high salt on  a  BioGel A-l.5m column (Bio-Rad 
Laboratories, Richmond,  CA) (23). 
Quantitative ELISA:  The molar ratio oftau to tubulin was determined 
in microtubules assembled from both gray matter (caudate nucleus) and white 
matter (internal  capsule). This was accomplished using a competitive ELISA. 
Purified tau or tubulin  was attached to microtiter plates at a concentration  of 
0.01 mg/ml. The plates were washed and blocked in a solution containing 20 
mM sodium phosphate buffer, pH 7.4, 0.13 M NaCl, 0.05% Tween-20, 0.4% 
BSA (bovine serum albumin)  (PBS-TA). Initial serial antibody dilutions were 
performed to determine the antibody concentration  that yielded an absorbance 
value corresponding to 60% of  the maximal absorbance obtained. This antibody 
concentration  was held constant in the presence of  a serial dilution of unbound 
protein  (either purified tubulin,  tau,  or an unknown sample). The antibody- 
protein suspension was preincubated at 37"C for l h and then plated onto the 
microtiter  plates which contained  preattached  tubulin  or tau (see above) and 
allowed to incubate  for  l  h more at 37°C. After incubation,  the  plates were 
washed  in  PBS-TA and  incubated  in  the  presence  of a  second  antibody 
peroxidase conjugate  for  1 h  at  room temperatlare. The plates  were again 
washed with PBS-TA, and an equal volume of substrate solution composed of 
pH 5.0 citrate-phosphate  buffer, 0.25 mg/ml o-phenylenediamine, and 0.003% 
H~O2 was added to each microtiter well. After 20 rain, the reaction was stopped 
with an equal volume of 0.65 M H2SO4, and the plates were read immediately 
on an ELISA reader at 492 nm. Standard curves were constructed by competing 
known amounts of tau or tubulin  in the soluble phase with the appropriate 
antibody and measuring the amount of uncomplexed antibody able to bind to 
bound tau or tubulin.  The amount of tau or tubulin  in unknown samples was 
determined by extrapolation of the linear regions of  the unknowns  to the linear 
portions of the standards. 
Immunohistochemical Procedures:  Male  Sprague-Dawley rats, 
150-250 g, were anesthetized with pentobarbital  (50 mg/kg) and intracardially 
perfused with 500 ml phosphate buffer (96 mM K2PO4, 24 mM NaH2PO4, pH 
7.4) containing  20 pM CaCI2, 2%  paraformaldehyde,  0.25% glutaraldehyde, 
and  15% (vol/vol) of a saturated  picric acid solution (20). The temperature  of 
the perfusate was adjusted to 38"C immediately before perfusion. After perfu- 
sion, the animal was decapitated and the head was immersed in fixative for 3- 
4 h. At this time, the brain was removed and stored in 4% paraformaldehyde 
in  phosphate  buffer  at  4"C  for  24  h.  The  next  day,  blocks of tiiIsue were 
transferred to 50 mM Tris-HCI, 130 mM NaCl, 5 mM KCI, 5 mM MgSO4, l 
mM EGTA, 0.05% NAN3, pH 7.6, (TBS) at 25"C containing  100 mM OL-lysine 
and  stored  at  4"C  with  continuous agitation  for  12-18 h.  All  procedures 
described below were performed  in TBS solution  unless otherwise specified. The tissue blocks were embedded  in 5% molten agar, sectioned to a thickness 
ranging from 40 to 60 #m with a vibratome,  and the resultant  sections were 
placed into ice-cold TBS and stored at 4°C for no more than 24 h. 
The unlabeled antibody  method (42) was used to identify the distribution 
of anti-beta-tubulin,  anti-MAP2,  and anti-tau  binding sites. Free-floating sec- 
tions were blocked for 3 h at 30"C in TBS containing 5% BSA and 1% normal 
rabbit serum before being placed in various dilutions  of primary antibody  in 
TBS containing 0.5 % BSA and 0.1% normal rabbit serum. Upon removal from 
primary antibody,  sections  were  washed  extensively in  TBS  without azide 
before unlabeled  antibody  treatment as described by Sternberger (42). After 
removal  from peroxidase-anfi-peroxidase  complex,  the  sections  were  again 
exhaustively  washed  in  TBS  without  azide  and  then  immersed  in  ehro- 
mogen solution containing  50 mM Tris-HC1, pH 7.6, at 25"C, 10 mM imida- 
zole,  0.04% 3,3'  diaminobenzidine  tetrahydrochloride,  and  0.0075%  H202 
(43). The reaction  was stopped  by immersing  the sections in  ice-cold TBS. 
After more washes, the sections were mounted on gelatinized slides, air-dried 
overnight and dehydrated in ethanol, cleared in xylene, and mounted. 
RESULTS 
Analysis and Specificity of Tau- 1 
The monoclonal antibody secreted by the hybridoma line 
Tau-I  was  shown  by double  immunodiffusion  tests  using 
isotype specific rabbit anti-mouse IgG antibodies to be of the 
IgG2a subclass (datanot shown). As expected, Tau-I  binds 
to  the  four polypeptides that  compose purified bovine tau 
(Fig.  1  E). Like a polyclonal antiserum recently reported (15), 
Tau- 1 binds to five polypeptides in extracts of gray and white 
matter (Fig.  1, A and B). The binding of a single monoclonal 
antibody to all five tau species in bovine brain is not unex- 
pected since the different tau polypeptides are known to have 
very similar peptide maps (11).  Nevertheless, the binding of 
Tau- 1 to five polypeptides in bovine brain raises the possibility 
that  the  hybridoma  line  producing  the  Tau-1  antibody  is 
impure and is therefore producing a mixture oftau antibodies. 
To eliminate this possibility, we subeloned our Tau- 1 produc- 
ing  hybridoma  line  an  additional  time  and  picked  seven 
independent clones. The antibody expressed by each individ- 
ual clone was tested against adjacent strips of blotted, purified 
tau. All clones produced antibodies that bound to the same 
four bands as the affinity purified Tau- 1 antibody (Fig.  1  E), 
thus proving that Tau-1 is a monoclonal antibody. 
Biochemical Localization  of Tau 
MAP2 and tau can bind to the same class of sites on the 
microtubule polymer in  vitro (23,  38).  However, immuno- 
cytochemical  studies  demonstrate  that  MAP2  is  localized 
mainly  in  the  dendrites  of neurons  in  situ.  Furthermore, 
analysis of microtubules purified from white matter- and gray 
matter-enriched  areas of brain  also  indicates  a  paucity of 
MAP2  in  in  vitro-assembled microtubules  from axon  en- 
riched  regions  (48).  Since  MAP2  is  known  to  bind  more 
tightly to  in  vitro-assembled microtubules than  is tau  (23, 
38),  we hypothesized that tau  would  be differentially com- 
partmentalized, perhaps being more abundant in the axonal 
or glial portions of  the nervous system. To test this, the soluble 
extracts  and  the  twice-cycled  microtubules  from  dissected 
white matter of the internal  capsule were compared by im- 
munoblotting with those from the  head of the caudate nu- 
cleus,  a  highly  enriched  gray  matter  brain  region.  Equal 
loadings of protein from soluble, crude extracts prepared from 
gray and  white  matter demonstrate that  significantly more 
tau is present in white matter preparations (compare Fig.  1, 
A, lanes 1 and 2 with B, lanes 1 and 2). Similarly, more tau 
immunoreactivity  is  evident  in  white  matter  twice-cycled 
microtubules than in equal loadings of microtubules assem- 
bled from gray matter extracts (compare Fig.  1,  D, lanes 1 
and  2  with  C,  lanes  1  and  2).  In  addition,  although  five 
immunoreactive tau  species are  present  in  soluble extracts 
from both white and gray matter (Fig.  1,  a  and  b),  during 
microtubule purification from gray matter extracts, the lowest 
molecular weight tau species (tau*) apparently binds poorly 
to the microtubule polymer and is efficiently removed after 
two cycles of assembly (Fig.  1  C).  In  contrast,  all  five tau 
species in white matter extracts (Fig.  1  B) appear to co-purify 
with microtubules through two cycles of assembly (Fig.  1  D). 
FIGURE  1  Qualitative  examination  of  the  relative 
amounts of tau  in gray matter vs. white  matter extracts 
and twice-cycled microtubules at two protein concentra- 
tions.  Immunoblots  of  (A)  a  soluble  extract  from  gray 
matter and  (B) a  soluble extract from white matter. The 
amount of protein loaded in A, lane I  equals the amount 
loaded in B, lane  1, and the amount of protein loaded in 
A, lane 2  equals the amount loaded in B,  lane 2.  Immu- 
noblots of twice-cycled microtubule preparation from (C) 
the  gray  matter extract shown  in A,  and  (D)  the  white 
matter extract shown in B. The same amounts of protein 
were loaded in C,  lane  I  and  D,  lane  1. The amount of 
protein loaded in C, lane 2 equals the amount of protein 
loaded in  D,  lane 2.  (E) 25  ng  of a  purified  bovine tau 
standard. Note the enrichment of tau* in D as compared 
with C, and also note that there is qualitatively more tau 
in  both white  matter extracts and  microtubules  than  in 
corresponding preparations from gray matter. The num- 
bers to the left represent molecular weight (x 10-3). 
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FIGURE  2  Quantitative determination of the amount of 
(A) tubulin and (B) tau in twice-cycled microtubules from 
a gray matter extract by competitive ELISA. In both assays 
the filled circles denote the standard curve and the open 
circles  represent  data  from  the  unknown  microtubule 
preparation  2XGM, twice-cycled  gray  matter  microtu- 
bules. Each  point is an average of six determinations +1 
SD. (A) @,/~-tubulin. O, 2XGM. (B) @, r. O, 2XGM. 
To quantify the difference between the microtubules puri- 
fied from white and gray matter-enriched brain regions (Fig. 
l, C and D) competitive ELISAs were performed (see Mate- 
rials and Methods).  We determined tau-to-tubulin ratios in 
the unknown samples of whole microtubules by the extrapo- 
lation to standard curves constructed using constant amounts 
of purified tau or tubulin bound to the microtiter plates. Serial 
dilutions of unbound tau or tubulin that had been preincu- 
bated with constant amounts of either Tau- 1 or an anti-beta- 
tubulin monoclonal antibody were then added to the ELISA 
plates,  and  the  relative  amounts  of bound  antibody  were 
measured. An example of such a determination is shown in 
Fig. 2, A and B, and the final results are summarized in Table 
I. Whereas the tau-to-tubulin ratio in gray matter microtu- 
bules  is  l  tau  per  38.4  tubulin  dimers,  the  ratio  in  white 
matter microtubules is three times higher at  1 tau per  12.8 
dimers. When combined with the data shown Fig.  1, C and 
D these results indicate that both qualitatively and quantita- 
tively, more tau is present in white matter microtubules than 
in  those  purified  from gray  matter.  Moreover,  since  gray 
matter preparations can contain as much as 40%  axons by 
volume (8) in addition to neuronal cell bodies and dendrites, 
while white matter preparations contain virtually no neuronal 
cell bodies or dendrites, tau would appear to be predominately 
axonal. However, both preparations also contain a multitude 
of glial  cells.  For this reason, immunohistochemical studies 
were performed to determine more precisely the localization 
of tau in brain tissue. 
Immunohistochemical  Localization  of Tau 
in  Brain 
Immunohistochemical studies were performed on adult rats 
after aldehyde fixation by vascular perfusions. Before we did 
this, we first had to establish the fidelity of our antibodies in 
binding to tau in rat brain. Immunoblot analysis of whole rat 
brain SDS extracts indicated that at least six electrophoretic 
species were present in the tau region of the gel (Fig.  3, lane 
B).  As  in  standard  microtubule  preparations  from  bovine 
brain (15), not all of these polypeptides co-purify with tubulin 
during temperature-dependent cycles of assembly and disas- 
sembly (Fig. 3, lane C). During microtubule purification from 
rat  brain,  it  appears  that  two  or  three  polypeptides  (also 
designated as tau*) are lost.  Furthermore, two of the  three 
remaining major tau  species resolve as doublets on our gel 
system (Fig.  3,  lane C),  indicating an enrichment of minor 
tau  polypeptides  during  microtubule  protein  purification 
from rat brain. 
Using the unlabeled antibody technique (42), we examined 
the  distribution  of tau  immunostaining in  rat  brain  at  the 
TABLE  I.  The Tau-to-Tubulin Ratios Obtained from Competitive 
ELISAs Performed  on Twice-cycled Microtubules from Both Gray 
and White Matter Extracts 
White matter  Gray matter 
MT  MT 
r (mg)  0.19 +  0.01  0.08 _+ 0.01 
~-Tubulin (mg)  2.19 _+ 0.19  2.77 _  0.10 
Molar ratio (r/tubulin)  1/12.8  1/38.5 
The indicated  amounts of protein (in milligrams) have been standardized to 
1 ml. The data are expressed as an average _+ 1 SD. The molar ratios were 
calculated using molecular weights of 55,000 for beta-tubulin and 61,000 for 
tau. MT, microtubules. 
FIGURE  3  Specificity  of  Tau-1 
in whole rat brain. Lane A, Coo- 
massie Blue stain of an SDS ex- 
tract of whole rat brain. Lane B, 
immunoblot of a lower concen- 
tration of the sample  in  lane A 
reacted  with  the  Tau-1  mono- 
clonal  antibody.  Unlike  bovine 
brain, rat brain contains at least 
six  immunoreactive  species  of 
tau.  Lane  C,  immunobtot  of  a 
twice-cycled  microtubule  prep- 
aration  from  whole  rat  brain. 
Note that two or three polypep- 
tides  (,)  are  lost  during  micro- 
tubule  purification.  The  num- 
bers to the left represent molec- 
ular weight (Xl0-a). 
level of the light microscope. After fixation (see Materials and 
Methods) vibratome sections were cut, and tissue staining was 
performed in cerebellum, medulla, and substantia nigra. In 
each case, tau immunostaining was contrasted with staining 
by both anti-beta-tubulin and anti-MAP2  monoclonal anti- 
bodies.  In the  hypoglossal nucleus  of the  medulla,  tubulin 
staining was seen in cell bodies, dendrites, and axons (Fig. 4 
A) whereas MAP2 was present mainly in dendrites and cell 
bodies,  with  little  axonal  staining  observable (Fig.  4B).  In 
contrast, tau localization was confined mainly to axons with 
no staining detectable in either cell bodies or dendrites (Fig. 
4 C). In the substantia nigra, cell bodies, dendrites, fine axonal 
fibers, and the axonal fiber bundles of the cerebral peduncles 
stained with anti-tubulin  antibody (Fig.  5A).  Again, MAP2 
localized  most  intensely  in  the  neuronal  cell  bodies  and 
dendrites (Fig.  5 B), and tau localization was largely comple- 
1374  THE  JOURNAL  OF  CELL  BIOLOGY  •  VOLUME  101,  1985 FiGUrE  4  Low-power micrographs o| vibratome sections through the hypoglossal  nucleus in the medulla immunostained with 
(A) an anti-beta-tubulin monoclonal antibody, (B) an anti-MAP2-monoclonal antibody, and (C) Tau-1.  ML,  medial lemniscus,  a 
large axon bundle. Xll, the cell mass  of the hypoglossa[ that gives rise to the twelfth cranial nerve. Note that the cell bodies and 
dendrites are stained by anti-tubulin and -MAP2  antibodies but not by Tau-1. The axons of the medial lemniscus are stained by 
anti-tubulin and Tau-1 but not by an anti-MAP2 monoclonal antibody. Bar, 80 ~m. 
mentary to the anti-MAP2 staining in that all observable anti- 
tau immunostaining appeared in the fine axonal fibers of the 
substantia nigra and in the peduncles (Fig. 5 C). Again, no tau 
localization was seen in cell bodies. 
We have also examined tau localization in the cerebellum. 
The most prominent immunoreactive processes in the molec- 
ular layer are the small parallel fiber axons (Fig. 6, A and B). 
As in the other brain areas examined the dendrites and gila 
were unstained by Tau-l. However, the result in the cerebel- 
lum is somewhat more striking since the heavy staining of the 
parallel fiber axons causes the unstained Purkinje cell bodies 
and dendrites  as well as the  processes of Bergmann gila to 
appear in negative relief(Fig. 6, A and B). 
DISCUSSION 
Biochemical experiments demonstrate that the concentration 
of tau in bovine brain tissue is greater in soluble extracts of 
white matter than in gray matter. In addition,  microtubules 
made from white matter contain  about threefold more tau 
than  those  purified  from gray matter, and  although  tau  is 
electrophoretically hetergeneous,  all  of its observable forms 
are  found  in  white  matter preparations.  Although  five tau 
polypeptides are observed in extracts of  bovine white and gray 
matter-enriched preparations, only four co-purify with gray 
matter  microtubules whereas  all  five co-purify with  white 
matter  microtubules.  The  polypeptide  species  that  is  lost 
during microtubule purification (tau*) was previously shown 
by Cleveland et al. (11) to be present in tau purified directly 
from crude extracts of brain tissue by heat treatment but was 
absent or present in greatly reduced quantities in microtubules 
purified by temperature-dependent cycles of assembly-disas- 
sembly (15). 
Immunocytochemical studies in rat brain using a monoclo- 
nal antibody that recognizes an epitope common to all of the 
tau polypeptides in bovine and rat brain extracts and micro- 
tubule  preparations extend  these  observations by revealing 
that  tau  immunoreactivity is  restricted to the  axonal com- 
partment of neurons and does not localize in glia. The exclu- 
sive localization of tau in axons as seen with our methods is 
supported by the following biochemical determinations. First, 
data from quantitative ELISAs show that there is three times 
more tau in microtubules made from white matter than in 
those assembled from gray matter. Because gray matter con- 
tains axons as well as dendrites and cell bodies (measurements 
indicate that a  conservative estimate for axonal volume in 
gray matter is  -40%  [8]),  it  is  clear that  some of the  tau 
protein  of gray matter arises from axonal sources.  Second, 
since our immunoblots indicate that there is less tau in soluble 
extracts of  gray matter than in white matter, the other cellular 
BINDER ET AL  Tau Localization in Brain Tissue  | 3 7 5 FIGURE 5  Low-power micrographs  of vibratome sections through the substantia nigra (SN) immunostained with (A) anti-beta- 
tubulin, (/3) anti-MAP2,  and (C) Tau-1. Note that the cerebral peduncles  (CP), an axon bundle, are stained intensely by the anti- 
beta-tubulin antibody (A) and Tau-1 (C), whereas only light staining is observable upon staining with an anti-MAP2  antibody (/3). 
Anti-tubulin and -MAP2 antibodies stain the dendrites and cell bodies (A and B); these are unstained by Tau-1 (C). The arrows 
point to fiber bundles in the substantia nigra that are stained with Tau-1 (C); a few of the corresponding areas not stained by anti- 
MAP2 (B) are indicated with asterisks. Bar, 80 #m. 
and  subcellular  compartments probably contain  little  tau. 
Such independent biochemical data support our immunocy- 
tochemical observations but do not prove that tau is exclu- 
sively axonal. Epitope masking due to protein-protein inter- 
actions or conformational changes in the tau molecule may 
result in  false negative determinations in other cellular and 
subcellular compartments. These caveats noted,  however, it 
is clear from the data presented that most tau is axonal. In 
support  of this,  sympathetic neurons  in  culture  have been 
subjected to the same biochemical analyses. In these cells,  it 
is possible to  separate physically the  axonal compartments 
from the cell body--dendritic compartments. Analysis of both 
preparations using either Tau-1  or a polyclonal antibody to 
tau also demonstrates that tau is largely axonal (Peng, I., L. I. 
Binder,  and M.  M.  Black,  manuscript in preparation).  The 
mechanisms underlying such differential localization are not 
known.  We will discuss two hypotheses. The  first involves 
differential MAP binding by different tubulin isoforms, and 
the second involves regional synthesis of MAP2 and tau. 
Competition  studies  comparing  the  relative  affinities  of 
MAP2 and tau for intact microtubules in vitro have shown 
that two classes of binding sites exist on in  vitro-assembled 
microtubules (23, 38). Although both classes allow binding of 
either protein, MAP2 will  displace tau from the MAP2 site 
and tau will displace MAP2 from the tau site.  Most of these 
sites have a  high  affinity for MAP2  and  the  rest display a 
higher affinity for tau than MAP2.  It is pertinent, however, 
that most standard tubulin preparations are made from ex- 
tracts  of bovine  cerebral  cortex,  an  enriched  gray  matter 
region  of the  brain  containing  a  composite  of dendrites, 
unmyelinated axons, neuronal cell bodies, and gila; it is not 
known whether similar results would be obtained if tubulin 
isolated from white matter were used in these experiments. 
That is, it is not known whether tau binds more tightly than 
MAP2 to white matter (axonal) tubulin. Indeed, the fact that 
tau* cycles with white  matter tubulin  but  not  gray matter 
tubulin strongly suggests that the tubulins of  these two regions 
differ, perhaps in isoform composition. Supporting this, dif- 
ferential localization of different tubulins within  single  cells 
in culture has been demonstrated (19, 44). Thus, our hypoth- 
esis suggests that the different MAP binding domains found 
on  in  vitro-assembled microtubules  from gray matter are 
specified by compartment-specific tubulins. MAP2-tau com- 
petition  experiments  performed  on  microtubules  isolated 
from both gray matter and white matter regions of the brain 
provide a means of testing this hypothesis. A second hypoth- 
esis, which to us seems less likely, is that differential localiza- 
tion  of tau  and  MAP2  arises  not  because  the  underlying 
tubulins in cell bodies and dendrites are different from those 
in  axons  but  because  MAP2  and  tau  are  synthesized  in 
different regions of the neuronal cell body. Although MAP2 
is known to be present in cell bodies (9, 13, 17), we have been 
unable  to  detect  tau  in  the  cell  body  proper  (see  below). 
Perhaps tau is synthesized at or near the  initial segment of 
the  axon and MAP2 is synthesized in  a  different cell  body 
compartment. 
Indeed, a perplexing aspect of the localization of Tau-1  is 
the fact that the neuronal cell bodies are unstained. The reason 
for this is unclear. Since axons contain no protein synthesizing 
machinery, tau  must be synthesized in  the  cell  bodies and 
transported into the axon. Either tau is in a form in cell bodies 
that will not bind the antibody or it is synthesized very near 
the somal-axonal junction and shunted immediately into the 
axons. This hypothesis could be tested by in situ hybridization 
studies using labeled tau cDNA to localize tau mRNA. 
The  work  presented  here  provides  few  clues  about  the 
1376  THE  JOURNAL OF  CELL BIOLOGY - VOLUME I01, 1985 FIGURE 6  High-power micrographs  of vibratome sections through a portion of the Purkinje  cell and molecular layers of the 
cerebellum immunostained with Tau 1.  (A) Section  through an  unstained  Purkinje  cell body (PC) showing continuity with  its 
unstained dendrites (d) that extend into the molecular layer towards the pial surface. Also unstained are the basket cell bodies 
(BC). (B) Section showing unstained  processes of Bergmann glia (BG plus arrow),  as well as numerous  unstained  Purkinje cell 
dendrites (d). The stippled appearance  provided by the positive staining in the molecular layer is due to the presence of thousands 
of parallel fiber axons that contain abundant tau. Bar, 25 ~.m. 
functional  reasons for the  heterogeneity of tau.  The  Tau-I 
monoclonal antibody reacts with all of the known tau poly- 
peptides in both rat and bovine brain. In bovine brain, extracts 
of the internal capsule contain all of the known tau species. 
However, additional experiments have shown that different 
tau species are predominant in different brain regions (Binder, 
L. I., A. Frankfurter, and L. I. Rebhun, manuscript in prep- 
aration, and reference 37).  Using a polyclonal antibody that 
reacts to all of the known tau polypeptides, Drubin et al. (15) 
have reported that the major immunoreactive species in PC 12 
cells is an Mr  ! 10,000-130,000  species. We have found that 
the major Tau-1 immunoreactive species in optic and periph- 
eral nerve (36, 37) is a doublet or triplet of polypeptides at Mr 
105,000-130,000  that accompanies varying numbers of the 
lower molecular weight tau bands (data not shown). In partic- 
ular, it is interesting that in  addition  to the high-molecular 
weight tau bands in optic nerve, we find predominantly two 
of the mid-molecular weight tau polypeptides, in agreement 
with the report of Tytell et al. (47).  It is highly unlikely that 
this heterogeneity is without function since during postnatal 
development the number of tau polypeptides changes from a 
single species early in development to the more complex adult 
forms by postnatal day 20  (16,  18). These changes parallel 
alterations in the electrophoretic complexity of MAP2 (4, 7) 
and tubulin  (14),  which suggests  that they are all tied to a 
common neuronal maturation process. Since our data suggest 
that tau is restricted to axons, developmental increases in the 
electrophoretic complexity of tau imply changes in the bio- 
chemical composition of axonal microtubules as compared 
with the microtubules in neuronal cell bodies, dendrites, and 
glia. 
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